Home

Susan L. Kelley

CIK 1519612 · last filed 2026-07-02

Susan L. Kelley is a corporate insider who has filed 46 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for DARE, was dated Jul 2, 2026. Current disclosed insider exposure totals $28.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$28.1K

Companies

4

Total Filings

46

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DARE Director 23,696 $1.19 $28.1K $0 12 2026-07-02
Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Director — $25.59 — $0 9 2024-06-11
IDYA Director — $36.16 — $0 6 2024-05-31
Dare Bioscience, Inc. (CERU) Delisted Director — — — $0 3 2016-06-24

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 DARE Grant (A) +23,696 $0 EDGAR
2026-06-11 DARE Grant (A) — $0 EDGAR
2025-07-10 DARE Grant (A) — $0 EDGAR
2024-06-11 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Disp (D) — $0 EDGAR
2024-06-07 DARE Grant (A) — $0 EDGAR
2024-05-31 IDYA Grant (A) — $0 EDGAR
2023-06-23 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Grant (A) — $0 EDGAR
2023-06-21 DARE Grant (A) — $0 EDGAR
2023-06-09 IDYA Grant (A) — $0 EDGAR
2023-01-19 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.